Pharmaceuticals Headlines from PR Newswire

< Go Back

Phase 3 DECISION Trial of NEXAVAR (sorafenib) in Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Cancer Refractory to Radioactive Iodine Published in The Lancet
Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2014 On April 29, 2014
DURECT Corporation Invites You to Join its First Quarter 2014 Earnings Conference Call
Pivotal Therapeutics announces resignation of directors
SYLVANTâ„¢ (siltuximab) Receives FDA Approval to Treat Multicentric Castleman's Disease (MCD)
Privateer Holdings Canadian Subsidiary, Tilray, Opens $10+ Million Cannabis Facility in British Columbia
NextDocs Sets Industry Standard for Scalability of Regulated Compliance Solutions
2014 CRO Quality Benchmarking - Phase I Service Providers
Health and Personal Care Suppliers and Pharmacists need to Diversify Pharmacy Businesses
TB Alliance Grants Fosun Pharma Rights to Develop, Market Promising TB Cure in China
New Tuberculosis Drug Regimen Will Move to Landmark Phase 3 Clinical Trial
Toxic Species of Parkinson's Protein Named Focus of Funding Program
CheckIssuing joins the Pharmaceutical Marketing Research Group
Orphan Drugs in Europe: Pricing, Reimbursement, Funding & Market Access Issues
Lupin Appoints Theresa Stevens as Chief Corporate Development Officer
Binimetinib Continues To Advance In Clinical Development
Pharmaceutical Packaging Market by Packaging Type, Raw Material & Drug Delivery Type - Global Trends & Forecast to 2018
Genpact to Acquire Leading Regulatory Affairs Company in Life Sciences
Global Gynecological Cancers Market 2014-2018
Eravacycline's Improvements in Efficacy and Delivery Over Competitors will Drive Uptake for the Treatment of Gram-Negative Infections due to Multidrug-Resistant Enterobacteriaceae
MiMedx at SAWC Spring 2014: Multiple Studies And Clinical Experience Demonstrate Clinical And Cost Effectiveness Of EpiFix Allograft For Treatment Of Hard-to-Heal Wounds
PerceptiMed Founder Jacobs To Speak At Bio2Device Group Event
WIRB-Copernicus Group's Chief Compliance Officer to Discuss Potential Impact of Corporate Consolidation on Human Research Protection Program Accreditation at 2014 AAHRPP Annual Conference
Two-Thirds of Americans Suffer from Allergies but Only Half See a Physician
New Drugs Offer Hope for Migraine Prevention
Vertellus Launches New Website, Reveals New Tagline
Generex Announces Antigen Express AE37 Breast Cancer Vaccine Abstract Presentations at ASCO 2014 Annual Meeting
Perrigo Company plc To Release Third Quarter Fiscal Year 2014 Results On May 7, 2014
Signature Exploration And Production Corp. Announces Name Change
Alzheimer's Drug Discovery Foundation Launches New Cognitive Vitality Site to Meet Critical Need in Alzheimer's Prevention and Education
Spreemo's Cloud-Based Healthcare Marketplace Expands with Statewide Radiology Coverage in California
mHealth Market Poised for Increased Investment in Various Levels of the Ecosystem Says Compass Intelligence
Cutting-edge Research to be Presented at 4th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica
Merck and Award-Winning Actress S. Epatha Merkerson Challenge Americans with Type 2 Diabetes to Get to Their Goals
Valeant Pharmaceuticals Announces Nominations For Board Of Directors
Debbie Allen, So You Think You Can Dance and Janssen Pharmaceuticals Create the T2 Dance Crew to Get People with Type 2 Diabetes Moving Spanish
AbbVie to Present Data on Investigational Compounds at the 2014 American Society of Clinical Oncology Annual Meeting
Lpath and Walter Reed Army Institute for Research Begin Efficacy Study Using Lpathomab in Traumatic Brain Injury Models
HemoShear Enters into R&D Collaboration with Medivir
Novartis recognized as top ranking company in the US on DiversityInc Top 50 Companies for Diversity list
Surefire Medical's Groundbreaking COSY Clinical Trial Results Presented at ECIO: Is Coiling Prior to Radioembolization Still Necessary in Minimally Invasive Treatment of Liver Cancer?
FDA Grants Orphan Drug Designation for Bayer's Investigational Ciprofloxacin DPI (Dry Powder for Inhalation) for Treatment of Non-Cystic Fibrosis Bronchiectasis
Hospira to Present at Upcoming Investor Conferences
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2014 Financial Results
Amgen's First Quarter 2014 Revenues Increased 7 Percent To $4.5 Billion
Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology
RXi Pharmaceuticals Enters into Financing Facility with Lincoln Park Capital
Japanese Sales Practices at Pharmaceutical Firms
Perceptimed Adds Majumdar To Management Team As VP Software Engineering And Development
China Pharmaceutical Distribution Industry Report, 2013

< Prev Next >
PR Newswire - United Business Media